Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate

Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate

Abstract The endocannabinoid system (ECS), a signalling network with immunomodulatory properties, is a potential therapeutic target in multiple sclerosis (MS). Dimethyl fumarate (DMF) is an approved drug for MS whose mechanism of action has not been fully elucidated; the possibility exists that its...

Full description

Bibliographic Details
Main Authors: Alicia Sánchez-Sanz, María Posada-Ayala, Julia Sabín-Muñoz, Ismael Fernández-Miranda, Yolanda Aladro-Benito, Roberto Álvarez-Lafuente, Ana Royuela, Ruth García-Hernández, Ofir Rodríguez-De la Fuente, Julián Romero, Antonio García-Merino, Antonio José Sánchez-López
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21807-y

Internet

https://doi.org/10.1038/s41598-022-21807-y

Similar Items